Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
Week 41 of America under the leadership of President Trump and the Trump Administration.
 - 
                            
VAUGHAN, Ontario, 15 oct. 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV : FLT | OTCQB : TAKOF | FSE : A3DP5Y) est heureuse d’annoncer la signature d’un protocole d’entente (« MOU ») avec...
 - 
                            
VAUGHAN, Ontario, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV: FLT | OTCQB: TAKOF | FSE: A3DP5Y) is pleased to announce that it has signed a Memorandum of Understanding (“MOU”)...
 - 
                            
NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Today, Italy and Nigeria, together with the Board Chair of the Global Partnership for Education (GPE), kicked off GPE’s 2026–2030 financing campaign at...
 - 
                            
DUBLIN, Sept. 09, 2025 (GLOBE NEWSWIRE) -- DIDWW, a global telecom provider of fully compliant phone numbers and premium-quality voice and SMS services, has expanded its SIP trunking coverage to...
 - 
                            
LOS ANGELES, July 16, 2025 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Expert Market: VDRM), a specialty pharmaceutical company, announced today that its 2024 Annual Report has been posted to the...
 - 
                            
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) projects €8.5 Billion revenue from its distribution agreements for Nigeria, Ukraine, UAE, Iraq, Syria, and Jordan.
 - 
                            
Meridianbet, part of Golden Matrix (NASDAQ: GMGI), expands B2B operations into Nigeria with a licensed launch, tapping into a $2B market and driving growth
 - 
                            
LOS ANGELES, Dec. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and topical antibiotic products, proudly announces the completion of a...
 - 
                            
LOS ANGELES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a specialty pharmaceutical company known for developing innovative transdermal drug delivery systems, is pleased to...